]>

IRCT20220809055645N5 IRCT 2023-05-26 Rasht University of Medical Sciences Outcomes of early discharge in patients with myocardial infarction Study the outcomes of early hospital discharge in patients with ST Elevation Myocardial Infarction after primary PCI 2023-06-05 anticipated 228 Complete https://irct.ir/trial/70271 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: -, Randomization description: In this study, in order to assign patients to intervention and non-intervention groups, a limited randomization approach with block randomization method will be used.Random allocation is considered based on 114 4-fold blocks. It is done through random allocation software.The sequence list of these patients is attached to the proposal. After the study, the list is kept in a sealed lock envelope at the Cardiac Research Center. After starting the study, this list is read daily and patients are placed in early discharge (A) and routine (B) groups according to the sequence of the list. N/A ST elevation (STEMI) myocardial infarction. Intervention 1: Intervention group: They will be discharged from hospital within 48 hours. Intervention 2: Control group: According to conventional protocol, they will be discharged from the department after more than 72 hours. Yes - There is a plan to make this available What will be shared: All data except personal information (name, contact number, file number) can be published. When: After publishing the results To whom: Available to service providers such as doctors and nurses. Conditions: After obtaining permission from the project manager, the information will be usable. Where to obtain: Project manager How to obtain: By email to the project manager Comments: -

public Fatemeh Baharvand

Kooye Bayani

Rasht Iran (Islamic Republic of) 41939-55588 +98 13 3366 4282 dr.baharcardio@gmail.com Rasht University of Medical Sciences scientific Fatemeh Baharvand

Kooye Bayani

Rasht Iran (Islamic Republic of) 41939-55588 +98 13 3366 4282 dr.baharcardio@gmail.com Rasht University of Medical Sciences Iran (Islamic Republic of) STEMI patients who undergo PCI primary with femoral access by an operator. no limit 75 years Both have had a life-threatening disease The left ventricular ejection fraction (LVEF) has been less than 30 percent. The patient's age is over 75 years old. The patient will have pulmonary edema ( Killip class II,III,IV) Each of the cases and criteria for occurrence of Major adverse cardiovascular events (MACE) included: acute myocardial infarction, acute coronary syndrome or ischemic heart disease (ACS/IHD), stroke (ischemic or hemorrhagic stroke), cardiovascular death (CV), and death by any cause. Patients who were readmitted. were not willing to continue to participate in the research. Perform Primary PCI with Radial Access were removed from the design. I21.3 ST elevation (STEMI) myocardial infarction of unspecified site Treatment - Other Treatment - Other Intervention group: They will be discharged from hospital within 48 hours. Control group: According to conventional protocol, they will be discharged from the department after more than 72 hours. Total deaths. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge. Myocardial Infarction. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state). Stroke. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: CT_SCAN MRI. Readmission. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge. Require Revocularization. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on patient reference records, in-person examination in weeks 2 and 6. Recurrent chest pain. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report and follow up after discharge. Arrhythmias. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state). Acute recurrent myocardial infarction. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state). Acute recurrent Coronary Syndrome. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Based on the ECG of the patient's blood pressure (relative to the basal state). Compliance to the drug. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Getting a report after discharge and during secondary referral to follow up the patient's heart condition. Lung edema. Timepoint: In the study, follow-up of patients during the 2nd and 6th weeks is performed in person by the attending physician to assess each of the mentioned outcomes. Method of measurement: Use the Killip class criterion. Rasht University of Medical Sciences Approved 2023-05-03 Research Ethics Committees of Guilan University of Medical Sciences Namjoo Rasht Guilan Iran (Islamic Republic of)